Rapid Therapeutic Science Laboratories, Inc. (RTSL) Revenue (2020 - 2021)
Rapid Therapeutic Science Laboratories' Revenue history spans 2 years, with the latest figure at $60.0 for Q4 2021.
- For Q4 2021, Revenue rose 100.66% year-over-year to $60.0; the TTM value through Sep 2022 reached $60.0, up 100.69%, while the annual FY2021 figure was $534.0, 99.59% down from the prior year.
- Revenue for Q4 2021 was $60.0 at Rapid Therapeutic Science Laboratories, up from $50.0 in the prior quarter.
- Across five years, Revenue topped out at $129287.0 in Q2 2020 and bottomed at -$63892.0 in Q1 2020.